Cetera Investment Advisers
BVS icon

Cetera Investment Advisers’s Bioventus BVS Stock Holding History

Cetera Investment Advisers’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,000
Closed -$221K – 3991
2024
Q4 		$221K Sell
21,000
-1,805
-8% -$21.3K ﹤0.01% 3359
2024
Q3 		$273K Buy
+22,805
New +$197K ﹤0.01% 3154

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cetera Investment Advisers's BVS Position: Q1 2025 in Review

Cetera Investment Advisers sold out of Bioventus (BVS) in Q1 2025, closing a stake of 21,000 shares — an estimated $221K sold.

Cetera Investment Advisers first reported a position in BVS in Q3 2024 and held it in 2 quarters. The position peaked at $273K in Q3 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Cetera Investment Advisers reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 21,000 Bioventus shares in Q1 2025, an estimated $221K.
  • Cetera Investment Advisers first reported a position in Bioventus in Q3 2024 and held it in 2 quarters.
  • Cetera Investment Advisers's Bioventus position peaked at $273K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Cetera Investment Advisers's 13F filing for Q1 2025, filed 6 May 2025.